-
Products_type
Antibody
-
Products_short_name
[RAMP1]
-
Products_name_syn
[Anti -RAMP1 (Receptor Activity Modifying Protein1)]
-
Other_names
[receptor activity-modifying protein 1; Receptor activity-modifying protein 1; receptor activity-modifying protein 1; OTTHUMP00000164475; CRLR activity-modifying protein 1; receptor activity modifying protein 1; receptor (calcitonin) activity modifying protein 1; calcitonin receptor-like receptor activity modifying protein 1; calcitonin-receptor-like receptor activity-modifying protein 1; receptor (G protein-coupled) activity modifying protein 1; Calcitonin-receptor-like receptor activity-modifying protein 1]
-
Other_gene_names
[RAMP1; RAMP1; RAMP1]
-
Clonality
Polyclonal
-
Reactivity
Human, Mouse, Rat
-
Specificity
Recognizes human RAMP1. Species sequence homology: mouse-52%, rat-91%. No significant sequence homology is detected with other RAMPs.
-
Purity
Affinity Purified Purified by immunoaffinity chromatography.
-
Form
Supplied as a liquid in 100mM Tris, pH 7.5, 0.2% BSA, 0.05% sodium azide, 40% glycerol.
-
Storage_stability
May be stored at 4 degree C for short-term only. For long-term storage, store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
-
Tested_application
ELISA (EL/EIA), Western Blot (WB)
-
Description
The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.